| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_217f2be73fd6be0be36dd55803d3bec5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-203 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-16 |
| filingDate |
2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6217a4fadebdababda39cf1e5917a647
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c2d3c02f06f121e9168d06ed53d2b4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc6d1fbffa2c545b3ec9d2431a044077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d22f7d01788b2e06d2a867373f92061e |
| publicationDate |
2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-107698602-A |
| titleOfInvention |
Polyketides with antitumor activity and preparation method and application |
| abstract |
The invention discloses polyketides with antitumor activity and preparation method and application.Polyketides 14 are prepared by streptomycete Steptomyces qinglanensis 1772205 enterocin gene cluster deletion mutations strain fermentation separation, shown in its structure such as formula (I).In vitro cytotoxic effect test result shows that 14 couples of tumour cell HeLa and MCF 7 of compound involved in the present invention show different degrees of inhibitory activity, and particularly compound 1 shows significant inhibitory action to tumour cell.Preferable candidate compound is provided to develop efficient antineoplastic. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110305881-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110305881-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114540376-A |
| priorityDate |
2017-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |